Catalysts for $ARGX
16 tracked
Oct 22, 2026
earnings
ARGENX SE earnings
ARGENX SE
→
Jul 23, 2026
earnings
ARGENX SE earnings
ARGENX SE
→
May 7, 2026
earnings
ARGENX SE earnings
ARGENX SE
→
Feb 26, 2026
approval
VYVGART HYTRULO (EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC) — FDA approval
ARGENX SE
→
Oct 17, 2025
approval
VYVGART (EFGARTIGIMOD ALFA) — FDA approval
ARGENX SE
→
Oct 17, 2025
approval
VYVGART HYTRULO (EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC) — FDA approval
ARGENX SE
→
Apr 10, 2025
approval
VYVGART HYTRULO (EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC) — FDA approval
ARGENX SE
→
Aug 8, 2024
approval
VYVGART (EFGARTIGIMOD ALFA) — FDA approval
ARGENX SE
→
Aug 8, 2024
approval
VYVGART HYTRULO (EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC) — FDA approval
ARGENX SE
→
Jul 24, 2024
approval
VYVGART (EFGARTIGIMOD ALFA) — FDA approval
ARGENX SE
→
Jun 21, 2024
approval
VYVGART HYTRULO (EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC) — FDA approval
ARGENX SE
→
Jun 21, 2024
approval
VYVGART HYTRULO (EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC) — FDA approval
ARGENX SE
→
Dec 12, 2023
approval
VYVGART (EFGARTIGIMOD ALFA) — FDA approval
ARGENX SE
→
Dec 12, 2023
approval
VYVGART HYTRULO (EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC) — FDA approval
ARGENX SE
→
Jun 20, 2023
approval
VYVGART HYTRULO (EFGARTIGIMOD ALFA AND HYALURONIDASE-QVFC) — FDA approval
ARGENX SE
→
Dec 17, 2021
approval
VYVGART (EFGARTIGIMOD ALFA) — FDA approval
ARGENX SE
→